Literature DB >> 3360731

Randomized trial of methylphenidate for an autistic child.

J M Strayhorn, N Rapp, W Donina, P S Strain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3360731     DOI： 10.1097/00004583-198803000-00019

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  10 in total

Review 1.  Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders.

Authors:  M G Aman; K S Langworthy
Journal:  J Autism Dev Disord       Date:  2000-10

2.  Analysis of WISC-III, Stanford-Binet:IV, and academic achievement test scores in children with autism.

Authors:  Susan Dickerson Mayes; Susan L Calhoun
Journal:  J Autism Dev Disord       Date:  2003-06

Review 3.  The use of psychostimulants in pervasive developmental disorders.

Authors:  Patricia Karen Abanilla; Greg A Hannahs; Robyn Wechsler; Raul R Silva
Journal:  Psychiatr Q       Date:  2005

4.  Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Authors:  Deborah A Pearson; Cynthia W Santos; Michael G Aman; L Eugene Arnold; David M Lane; Katherine A Loveland; Rosleen Mansour; Anthony R Ward; Charles D Casat; Susan Jerger; Russell J Schachar; Oscar G Bukstein; Lynne A Cleveland
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-07-09       Impact factor: 2.576

5.  Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Authors:  B L Handen; C R Johnson; M Lubetsky
Journal:  J Autism Dev Disord       Date:  2000-06

6.  Use of methylphenidate in the treatment of children with autistic disorder.

Authors:  H Quintana; B Birmaher; D Stedge; S Lennon; J Freed; J Bridge; L Greenhill
Journal:  J Autism Dev Disord       Date:  1995-06

7.  The comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: results of a retrospective chart review.

Authors:  Sam Goldstein; Adam J Schwebach
Journal:  J Autism Dev Disord       Date:  2004-06

8.  WISC-IV and WIAT-II profiles in children with high-functioning autism.

Authors:  Susan Dickerson Mayes; Susan L Calhoun
Journal:  J Autism Dev Disord       Date:  2007-07-04

9.  Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Authors:  Deborah A Pearson; Cynthia W Santos; Michael G Aman; L Eugene Arnold; Charles D Casat; Rosleen Mansour; David M Lane; Katherine A Loveland; Oscar G Bukstein; Susan W Jerger; Perry Factor; Salome Vanwoerden; Evelyn Perez; Lynne A Cleveland
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-06       Impact factor: 2.576

Review 10.  Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Authors:  Carolyn A Doyle; Christopher J McDougle
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.